The US Food and Drug Administration has reversed course and will review a new mRNA flu vaccine from Moderna, the pharmaceutical company said Wednesday, ...

The NJ DEP has received over 1,100 calls for dead wild birds. Harsh winter conditions and possible bird flu are suspected ...

Flu season is not over yet, experts warn. Is there a second wave coming? Here's how to protect yourself as influenza keeps spreading.

Last month, cases of flu reached their highest levels in the United States in 25 years. Many hospitals were unprepared for ...

From a potential new flu vaccine to a groundbreaking surgical first and critical health reminders, here's today's essential health news.

The pharmaceutical giant expressed optimism that its new flu shot would be available this year, after approval concerns.

“We are heading up a second peak of flu season,” said Caitlin Rivers, a Johns Hopkins University epidemiologist who writes ...

Add Yahoo as a preferred source to see more of our stories on Google. Why would Sacramento State spend tens of millions to join the MAC? 'It is putting the university on the map' The Coach Outlet ...

The agency previously told Moderna its application did not contain an “adequate and well-controlled” trial.

In a winter marked by flu outbreaks, the persistence of Covid-19, and surges of measles cases across the United States, an Annenberg survey finds that a sizable majority of Americans think the three ...

The US Food and Drug Administration has refused to accept an application from Moderna to review its first mRNA seasonal flu vaccine, the company said Tuesday, in another setback for the technology ...

The U.S. Food and Drug Administration announced recently that it will not review Moderna’s mRNA flu vaccine, despite late-stage trials showing it was safe and effective. The rejection has many in and ...